Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
231.80
-1.55 (-0.66%)
BSENSE

Nov 20

BSE+NSE Vol: 1.62 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
520.17
467.50
475.61
445.36
484.67
439.67
390.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
520.17
467.50
475.61
445.36
484.67
439.67
390.21
Raw Material Cost
127.63
104.58
109.18
97.89
112.99
105.53
85.86
Purchase of Finished goods
55.79
39.89
32.52
32.99
38.82
39.23
30.62
(Increase) / Decrease In Stocks
-3.58
13.58
-0.69
-10.46
-6.47
-9.79
-10.51
Employee Cost
105.11
101.41
109.41
106.03
103.23
107.02
106.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
20.98
18.54
17.76
18.31
21.81
21.66
17.39
Other Expenses
167.81
148.48
157.72
169.09
171.24
158.49
161.31
Total Expenditure (Excl Depreciation)
473.74
426.48
425.90
413.85
441.62
422.14
390.99
Operating Profit (PBDIT) excl Other Income
46.43
41.02
49.71
31.51
43.05
17.53
-0.78
Other Income
1.97
2.18
-0.04
0.98
0.76
1.63
2.02
Operating Profit (PBDIT)
48.40
43.20
49.67
32.49
43.81
19.16
1.24
Interest
26.91
28.29
45.92
25.64
24.56
26.12
17.98
Exceptional Items
37.14
97.34
3.74
-6.15
-0.53
0.00
0.00
Gross Profit (PBDT)
58.63
112.25
7.49
0.70
18.72
-6.96
-16.74
Depreciation
34.44
34.53
32.49
32.01
32.25
29.70
28.78
Profit Before Tax
24.19
77.72
-25.00
-31.31
-13.53
-36.66
-45.52
Tax
4.72
12.28
-1.32
-1.86
-4.32
-0.31
-4.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.47
65.44
-23.68
-29.45
-9.21
-36.35
-41.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.47
65.44
-23.68
-29.45
-9.21
-36.35
-41.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.09
0.45
-2.04
0.34
-1.28
-0.56
-0.95
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18.38
64.99
-21.64
-29.79
-7.93
-35.79
-40.39
Equity Capital
18.46
18.46
18.46
18.45
18.45
18.45
18.45
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
1.99
7.04
-2.34
-3.23
-0.86
-3.88
-4.38
Diluted Earnings per share
2.11
7.09
-2.56
-3.19
-1.0
-3.94
-4.48
Operating Profit Margin (Excl OI)
9.16%
8.8%
10.9%
7.25%
9.12%
4.07%
-0.2%
Gross Profit Margin
11.57%
24.08%
1.64%
0.16%
3.97%
-1.62%
-4.36%
PAT Margin
3.84%
14.04%
-5.19%
-6.78%
-1.95%
-8.44%
-10.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 11.27% vs -1.71% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is -71.72% vs 400.32% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 13.19% vs -17.48% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -4.88% vs -38.39% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Indoco Remedies With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
520.17
87.42
432.75
495.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
520.17
87.42
432.75
495.02%
Raw Material Cost
127.63
49.07
78.56
160.10%
Purchase of Finished goods
55.79
0.00
55.79
(Increase) / Decrease In Stocks
-3.58
-3.33
-0.25
-7.51%
Employee Cost
105.11
9.76
95.35
976.95%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
20.98
0.00
20.98
Other Expenses
167.81
7.57
160.24
2,116.78%
Total Expenditure (Excl Depreciation)
473.74
63.07
410.67
651.13%
Operating Profit (PBDIT) excl Other Income
46.43
24.35
22.08
90.68%
Other Income
1.97
0.28
1.69
603.57%
Operating Profit (PBDIT)
48.40
24.63
23.77
96.51%
Interest
26.91
2.00
24.91
1,245.50%
Exceptional Items
37.14
0.00
37.14
Gross Profit (PBDT)
58.63
22.63
36.00
159.08%
Depreciation
34.44
6.60
27.84
421.82%
Profit Before Tax
24.19
16.02
8.17
51.00%
Tax
4.72
4.71
0.01
0.21%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
19.47
11.31
8.16
72.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
19.47
11.31
8.16
72.15%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
1.09
0.00
1.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.38
11.31
7.07
62.51%
Equity Capital
18.46
22.25
-3.79
-17.03%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
1.99
5.08
-3.09
-60.83%
Diluted Earnings per share
2.11
5.08
-2.97
-58.46%
Operating Profit Margin (Excl OI)
9.16%
27.85%
0.00
-18.69%
Gross Profit Margin
11.57%
25.89%
0.00
-14.32%
PAT Margin
3.84%
12.94%
0.00
-9.10%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 520.17 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 11.27% vs -1.71% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 7.32% vs 12.02% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 18.38 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -71.72% vs 400.32% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 331.78% vs 17.14% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.43 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 13.19% vs -17.48% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 7.85% vs 6.96% in Sep 2025

Quarterly - Interest
Interest 26.91 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -4.88% vs -38.39% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 9.57% vs 37.75% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.16%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025